Search

Author/Creator Munn, David

1. A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2, 3 dioxygenase expression. Issue 1 (December 2017)

Authors:
Mangaonkar, Abhishek; Mondal, Ashis Kumar; Fulzule, Sadanand; Pundkar, Chetan; Park, Eun Jeong; Jillella, Anand; Kota, Vamsi; Xu, Hongyan; Savage, Natasha; Shi, Huidong; Munn, David; Kolhe, Ravindra
Journal:
Scientific reports
Issue:
Volume 7:Issue 1(2017)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. CTIM-32. FIRST-IN-CHILDREN PHASE 1 TRIAL OF INDOXIMOD-BASED CHEMO-IMMUNOTHERAPY FOR PATIENTS WITH PEDIATRIC BRAIN TUMORS: ANALYSIS OF SAFETY, TOLERABILITY, AND 5-YEAR OUTCOME. (14th November 2022)

Authors:
Johnson, Theodore; Pacholczyk, Rafal; Aguilera, Dolly; Al-Basheer, Ahmad; Bajaj, Manish; Bandopadhayay, Pratiti; Berrong, Zuzana; Bouffet, Eric; Castellino, Robert; Dorris, Kathleen; Eaton, Bree; Esiashvili, Natia; Foreman, Nicholas; Fridlyand, Diana; Giller, Cole; Heger, Ian; Kadom, Nadja; Kenne...
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii68
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. EPEN-13. OUTCOMES AFTER FIRST RELAPSE OF CHILDHOOD INTRACRANIAL EPENDYMOMA: A SINGLE INSTITUTION EXPERIENCE. (23rd April 2019)

Authors:
Manoharan, Neevika; Zimmerman, Mary Ann; Scully, Jacqueline; Chordas, Christine; Clymer, Jessica; Wright, Karen; Filbin, Mariella; Ullrich, Nicole J; Munn, David; Johnson, Theodore; Chi, Susan; Bandopadhayay, Pratiti; Yeo, Kee Kiat
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 2
Page Start:
ii80
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma. Issue 6 (11th June 2021)

Authors:
Zakharia, Yousef; McWilliams, Robert R; Rixe, Olivier; Drabick, Joseph; Shaheen, Montaser F; Grossmann, Kenneth F; Kolhe, Ravindra; Pacholczyk, Rafal; Sadek, Ramses; Tennant, Lucinda L; Smith, Christopher M; Kennedy, Eugene P; Link Jr, Charles J; Vahanian, Nicholas N; Yu, Jiayi; Shen, Steven S; B...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 6(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The PTEN pathway in Tregs functions as a critical driver of the immunosuppressive tumor microenvironment and tolerance to apoptotic cells. (4th November 2015)

Authors:
Sharma, Madhav; Shinde, Rahul; McGaha, Tracy; Huang, Lei; Holmgaard, Rikke; Wolchok, Jedd; Mautino, Mario; Celis, Esteban; Sharpe, Arlene; Francisco, Loise; Powell, Jonathan; Yagita, Hideo; Mellor, Andrew; Blazar, Bruce; Munn, David
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. The PTEN pathway in Tregs functions as a critical driver of the immunosuppressive tumor microenvironment and tolerance to apoptotic cells. Issue 2 (December 2015)

Authors:
Sharma, Madhav; Shinde, Rahul; McGaha, Tracy; Huang, Lei; Holmgaard, Rikke; Wolchok, Jedd; Mautino, Mario; Celis, Esteban; Sharpe, Arlene; Francisco, Loise; Powell, Jonathan; Yagita, Hideo; Mellor, Andrew; Blazar, Bruce; Munn, David
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗